Manipal Health Enterprises is set to launch its IPO tomorrow, having already secured ₹4,167 crore from marquee anchor investors including Morgan Stanley and Goldman Sachs.
The Grey Market Premium (GMP) currently suggests modest listing gains, reflecting investor confidence despite recent reports of internal shareholder disputes.
The issue will be closely watched as a benchmark for healthcare sector valuations in the current fiscal year, with analysts focusing on the company's expansion plans.